Skip to main content
CriticalFDAfda-F-0555-2018UNDECLARED ALLERGEN

Choceur Dark Chocolate Bars, 5.29 oz., 20 units/case

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Units Affected
93,500
Recall Date
December 5, 2017
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0555-2018.

ALDI has voluntarily recalled Choceur Dark Chocolate Bars due to the potential presence of almond pieces, which are an undeclared treenut allergen.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0555-2018.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Aldi Inc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0555-2018.

Aldi Inc

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Aldi Inc Recall FAQ

Aldi Inc is the subject of a snacks & candy safety report: Choceur Dark Chocolate Bars, 5.29 oz., 20 units/case. The notice was published on December 5, 2017 by the U.S. Food and Drug Administration (FDA). Approximately 93,500 units are potentially affected.